Risk factors for postnatal mother-child transmission of HIV-1

AIDS

Volumn 14, Issue 16, 2000, Pages 2535-2541

  Embree, Joanne E ^a,b   Njenga, Simon ^b   Datta, Pratibha ^b   Nagelkerke, Nico J D ^a,b   Ndinya Achola, Jeckoniah O ^b   Mohammed, Zeena ^a   Ramdahin, Sue ^a   Bwayo, Job J ^b   Plummer, Francis A ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Africa; Breastfeeding; CD4 cell count; HIV 1; Mastitis; Mother to child transmission; Thrush

Indexed keywords

CD4 ANTIGEN;

ADULT; AFRICA; ARTICLE; BREAST FEEDING; CELL COUNT; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; PERINATAL PERIOD; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEROCONVERSION; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

BREAST FEEDING; CANDIDIASIS, ORAL; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; INFANT, NEWBORN; MASTITIS; RISK FACTORS;

EID: 0033730744     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200011100-00016     Document Type: Article

References (54)

1. Potential risk factors for vertical HIV-1 transmission in Catalonia, Spain: The protective role of Cesarean section. The Working Group on HIV-1 Vertical Transmission in Catalonia
2. Mother-to-child transmission of human immunodeficiency virus type 1: Report from the Nairobi Study
3. Breast-feeding during primary maternal human immunodeficiency virus infection and risk of transmission from mother to infant
4. Risk of human immunodeficiency virus type 1 transmission through breastfeeding
5. Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda
6. HIV-1 transmission through breast-milk:apprasial of risk according to duration of feeding
7. Infant feeding and risk of mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1
8. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Motherto-Child Transmission of HIV
9. Breastfeeding by HIV-1 infected women and outcomes in their infants: A cohort study from Durban, South Africa
10. Late postnatal transmission of human immunodeficiency virus type 1 infection from mothers to infants in dares Salaam, Tanzania
11. Late postnatal mother-tochild transmission of HIV-1 in Abidjan, Cote d'lvoire
12. Estimating the timing of mother-to-child transmission of human immunodeficiency virus in a breast-feeding population in Kinshasa, Zaire
13. HIV transmission through breastfeeding. A study in Malawi
14. High incidence of early postnatal transmission of human immunodeficiency virus type 1 in Bangui, Central African Republic
15. Reduction of maternalinfant transmission of human immunodeficiency virus type 1 with zidovudine treatment
16. Analysis of the maternal components of the AIDS Clinical Trial Group 076 zidovudine regimen in the prevention of mother-to-infant transmission of human immunodeficiency virus type 1
17. A 'bloodless caesarean section' and perinatal transmission of human immunodeficiency virus
18. Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women
19. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone
20. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand, 1996-1998
21. Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in Pediatric AIDS Clinical Trials Group Protocol 076
22. Impact of zidovudine use on risk and risk factors for perinatal transmission of HIV. Perinatal AIDS Collaborative Transmission Studies
23. Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States
24. Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus
25. After AIDS Clinical Trial 076: The changing pattern of zidovudine use during pregnancy, and the subsequent reduction in the vertical transmission of human immunodeficiency virus in a cohort of infected women and their infants. Women and Infants Transmission Study Group
26. Prevention of perinatal transmission of human immunodeficiency virus: A progress report 2 years after completion of AIDS Clinical Trials Group Trial 076
27. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties
28. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
29. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus
30. 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote d'lvoire and Burkina Faso: A double-blind placebo-controlled multicentre trial
31. Short-course zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote d'lvoire: A randomised trial
32. Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: A randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group
33. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
34. Caesarean section and risk of vertical transmission of HIV-1 infection
35. Determinants of mother-to-child transmission of human immunodeficiency virus type 1 infection in a cohort from Durban, South Africa
36. Perinatal HIV-1 transmission. Interaction between zidovudine prophylaxis and mode of delivery in the French perinatal cohort
37. Prevention of mother-to-child transmission of HIV-1 infection: Alternative strategies and their cost effectiveness
38. Prevention of vertical HIV transmission: Additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group
39. Cesarean deliveries and maternal-infant HIV transmission: Results from a prospective study in South Africa
40. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1
41. Breast-feeding/breast milk and human immunodeficiency virus (HIV)
42. Development of oligonucleotide primers and probes against structural and regulatory genes of human immunodeficiency virus type 1 (HIV-1) and their use for amplification of HIV-1 provirus by using polymerase chain reaction
43. 1994 Revised guidelines for the performance of CD4+ T-cell determination in persons with immunodeficiency virus (HIV) infections
44. The duration of breastfeeding by HIV-1-infected mothers in developing countries: Balancing benefits and risks
45. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: A prospective cohort study
46. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: Effect of maternal zidovudine treatment on viral load
47. Maternal plasma human immunodeficiency virus type 1 RNA level: A determinant and projected threshold for mother-to-child transmission
48. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
49. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
50. Human immunodeficiency virus load in breast milk, mastitis and mother-to-child transmission of human immunodeficlency virus type 1
51. Acquired resistance and persistance of Candida albicans following oral candidiasis in the mouse: A model of the carrier state in humans
52. Local and systemic host defense mechanisms against Candida: Immunopathology of candidal infections
53. Treatment of oralpharyngeal candidiasis and candidal diaper dermatitis in neonates and infants: Review and reappraisal